Wednesday, April 26, 2017

NYX: 2017 May Be The Year Of The Catalyst


4Q16 results positive with revenue growth and margin improvements as expected.
Impairments of 94m surprisingly high but due to management decisions of migrating customers to a better platform.
Listing on the TSX in the second semestre of 2017 may be the catalyst and improved liquidity needed.
A guidance for 1Q17 was provided, while revenues fall within my expectations, EBITDA margins fall short of my expectations.
I recommend buying CVE:NYX with a target price of CAD 4.70/sh and OTC:NXXY with a target price of USD 3.45/sh.

Read more...

No comments:

Post a Comment

Becoming A Venture Capitalist Through Overstock

Summary Blockchain is an interesting technology that may end up disrupting many industries. Overstock owns Medici, a venture capital...